Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.10.03.616587

Novel insights into IKur modulation by Lgi3-4: Implications in atrial fibrillation

Abstract

BackgroundPatients with atrial fibrillation (AF) exhibit a reduction in the ultrarapid outward potassium current (IKur) conducted by KV1.5 channels. Ion channels are closely modulated by regulatory subunits, forming macromolecular complexes known as channelosomes. One such regulatory family is the leucine-rich glioma-inactivated protein family (Lgi1-4), which has been shown to interact with KV1, modifying their trafficking and/or biophysical properties in neurons. However, the expression and impact of these proteins in the heart is still unknown. We investigated the role of Lgi3-4 proteins in cardiac electrophysiology, focusing specifically on IKur, and their potential contribution to the pathophysiology of AF. MethodsWe used three complementary biological systems, including heterologous COS-7, HEK297 and CHO cells, AAV-mediated cardiac-specific Lgi4 gene transfer in mice (Lgi4 mice), and human samples from patients in sinus rhythm and AF. Our multidisciplinary approach included immunolocalization, patch clamping, surface ECG, transvenous catheter-mediated intracardiac stimulation, and molecular biology techniques. ResultsOnly Lgi3 and Lgi4 were expressed in the human heart. In human atrial tissue and heterologous cells, Lgi3 and Lgi4 interacted with KV1.5 channels. In HEK293 cells, Lgi3-4 impaired KV1.5/KV{beta} association, partially reversing the KV{beta}-induced N-type inactivation and reducing IKur amplitude. On surface ECG, the QRS interval was prolonged, and impulse conduction was impaired in cardiac-specific Lgi4 mice compared with control. In isolated ventricular cardiomyocytes from Lgi4 mice, early action potential repolarization was prolonged compared to control cardiomyocytes. These results correlated with the reduced KV1.5 membrane expression and IKur density observed in Lgi4 cardiomyocytes and HEK293 cells. Notably, Lgi4 protein expression was lower in atrial tissue from patients with AF than sinus rhythm patients. The reduction in Lgi4 protein levels in AF was also associated with an altered colocalization with KV1.5 channels, suggesting potential disruptions in their functional interactions. ConclusionsLgi3-4 proteins are new components of the KV1.5 channelosome. They modulate IKur by interfering with KV1.5 interaction with the KV{beta} subunit. Importantly, Lgi4 is dysregulated differently in paroxysmal versus permanent AF. The results improved the understanding of this most common type of arrhythmia and identified Lgi proteins as a new potential target for treatment. NOVELTY AND SIGNIFICANCEWhat is known? O_LILeucine-rich glioma-inactivated protein family (Lgi1-4) exert an important role in the nervous system and neurological diseases. In neurons, certain Lgi proteins interact with KV1 channels, modifying their trafficking and/or biophysical properties. C_LIO_LIIn cardiomyocytes, the activation of KV1.5 channels generates the ultrarapid outward potassium current (IKur), which is essential for the initial phase of human atrial repolarization, and it is dysregulated in AF. C_LIO_LIChanges in the properties or functional expression of some KV1.5 interacting proteins have crucial pathophysiological consequences. C_LI What new information does this article contribute? O_LIWe demonstrate that Lgi3-4 are novel components of KV1.5 channelosome, modulating IKur and hence human atrial electrophysiology. Lgi3-4 proteins decrease IKur by interfering with the interaction between KV1.5 and KV{beta} subunits. C_LIO_LIThe decrease in IKur in cardiac-specific mouse model expressing Lgi4 slows the early repolarization in the action potential, as well as produce electrophysiological changes in the surface ECG and the cardiac conduction system. C_LIO_LILgi4 is dysregulated differently in paroxysmal (PX) versus permanent (PM) AF, thus shedding light into the mechanisms underlying this cardiac arrhythmia. C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Socuellamos, P. G., Macias, A., de Benito-Bueno, A., Cruz, F. M., Redondo-Moya, M., Coronado, M. J., Ramil, E., Rosado, S., Rios-Rosado, E. C., Valencia-Avezuela, M., de Andres-Delgado, L., Blazquez Gonzalez, J. A., Forteza-Gil, A., Gutierrez-Rodriguez, M., Jalife, J., Valenzuela, C.. 2024-10-06. Novel insights into IKur modulation by Lgi3-4: Implications in atrial fibrillation. https://doi.org/10.1101/2024.10.03.616587

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Cholinergic impairment in the dorsal motor nucleus of the vagus during experimental Alzheimer's disease

Cholinergic neurons in the dorsal motor nucleus of the vagus (DMN) in the brainstem are a key source of efferent vagus nerve fibers that regulate vital functions, including heart rate and inflammation. Whether the integrity of DMN cholinergic neurons is affected during Alzheimer's disease (AD) remains unknown. Here, in female and male mice with experimental AD (5xFAD), which exhibit age-dependent memory impairment, basal forebrain cholinergic neurodegeneration, and microglial alterations, we observe a reduction in cholinergic neuron density in the DMN at 6 and 10 months of age. Furthermore, while an important physiological function of DMN cholinergic signaling, such as suppression of heart rate, is preserved in control mice upon electrical DMN stimulation, the extent of suppression diminishes with age in both female and male 5xFAD mice. In addition, while electrical DMN stimulation lowers pro-inflammatory cytokine levels in control mice subjected to endotoxemia, this anti-inflammatory effect is diminished with age in 5xFAD mice, with females showing earlier dysfunction at 6 months. These results reveal previously unrecognized age-dependent cholinergic deficits in the DMN and disrupted brain - to - periphery vagus nerve circuits in experimental AD. These findings advance our understanding of AD mechanisms and are of interest for the development of conceptually novel therapies.

physiology↗

Ketogenic diet is protective during endotoxin-induced lung injury through the elevation of BHB

Acute respiratory distress syndrome (ARDS) is marked by severe pulmonary edema and concomitant hypoxia, affecting hundreds of thousands of people a year, especially those in critical care conditions or suffering from septic shock. Previous studies have implicated that the ketogenic diet, a high-fat and low-carbohydrate diet, modulates inflammatory responses. However, the impact of the ketogenic diet on septic ARDS outcomes is unknown. Here, we demonstrated that mice on a ketogenic diet showed strikingly reduced lung injury and inflammation compared to those on a control diet during a murine model of endotoxin-induced lung injury, induced by intratracheal lipopolysaccharide (LPS) injection. Immune mass cytometry studies on lung tissue indicated that the ketogenic diet reduces immune cell infiltration. Treating mice with beta-hydroxybutyrate (BHB), the primary metabolite of ketogenesis, after the onset of ARDS reduced pulmonary edema and lung inflammation, as well as NF-kB activity, suggesting strong therapeutic potential. By multiplex analysis in bronchial alveolar lavage fluid, we observed that the ketogenic diet or BHB administration attenuates the chemotaxis and activation of immune cells. Altogether, our findings reveal that the ketogenic diet provides lung protection during endotoxin-induced lung injury through BHB.

physiology↗

Efficacy of postmenopausal estrogen replacement in SIV-infected female macaques on antiretroviral therapy.

The success of modern antiretroviral therapy (ART) has increased the life expectancy of people living with HIV to levels approaching that of uninfected individuals. For women living with HIV (WLWH), this means that more will survive to undergo menopause and experience the consequences of decreased ovarian hormone levels, particularly estrogen (E2). The recent change in federal guidance for use of postmenopausal hormone therapy is increasing demand for both E2-alone and E2+progestogen formulations to control adverse symptoms of menopause. The consequences and efficacy of hormone therapy in WLWH are thus an important issue for WLWH and their healthcare providers. The role of E2 replacement in postmenopausal WLWH is a significant issue because of its potential effects on control the viral reservoir and its demonstrated beneficial metabolic effects in uninfected postmenopausal women. To address these questions, we employed a novel nonhuman primate model of postmenopausal WLWH undergoing E2 replacement. Reproductively competent female rhesus macaques were infected with simian immunodeficiency virus (SIV) and then subjected to a daily ART regimen. After complete suppression of plasma viremia, all animals were ovariectomized (OVX) and then implanted with Silastic capsules containing either cholesterol vehicle or sufficient E2 to restore pre-OVX plasma levels. Plasma and cell-associated viral dynamics, immune responses, body composition, systemic and tissue-specific metabolic parameters, cytokine profiles, and parameters of bone health were followed longitudinally from baseline through 34 weeks of E2 deficiency or replacement. We found that E2 status did not significantly affect plasma or tissue viral dynamics or overall metabolic homeostasis. However, E2 replacement exerted beneficial effects on several aspects of bone health in spite of a chronic inflammatory state that persisted following effective ART suppression of the SIV reservoir. Our findings suggest that hormone therapy, specifically E2 replacement, offers benefit to WLWH, particularly with respect to bone loss.

physiology↗